ANETA GRZYMALA: Open Payments
NPI 1003557356 · HIGHLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 3 payments from 3 companies in 2025. Trend: 2023 $249 · 2024 $703 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $95 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA.
Industry payments across IL — which companies pay providers there.
